Analysis on the risk factors and anti-infective treatment of stroke-associated pneumonia in NICU in our hospital
CHOU Xiaohua1 GAO Xing1 LIU Tianya1 WANG Fengzhen1 HAN Qiang1 ZHANG Xiancheng2
1.Department of Pharmacy, Affiliated Hospital of Xuzhou Medical University, Jiangsu Province, Xuzhou 221006, China;
2.School of Pharmacy, Xuzhou Medical University, Jiangsu Province, Xuzhou 221004, China
Abstract:Objective To analyze the risk factors and pathogens characteristics of stroke-associated pneumonia in neurological intensive care unit (NICU) of Affiliated Hospital of Xuzhou Medical University ("our hospital" for short), so as to provide evidence for antimicrobial drug choice. Methods Clinical data of 154 patients with stroke from January 2016 to June 2017 in our hospital. The multivariate Logistic regression analysis was used to analyze the risk factors of stroke-associated pneumonia, and the main pathogenic bacteria and drug resistance statistically. It was studied that how to carry out effective anti-infective therapy on the main pathogens. Results Multivariate regression analysis showed significant differences (P < 0.05) in several factors such as age≥65 years, diabetes, dysphagia, hyperglycemia,hypoproteinemia,and high leukocyte count. The main pathogens were G- bacteria 59.09% in proportion, the top three major pathogens were Klebsiella pneumoniae, Staphylococcus aureus and Pseudomonas aeruginosa. The main pathogens showed severe multidrug resistance. G- bacteria were more sensitive to Tigecycline, Amikacin and so on. Staphylococcus aureus was more sensitive to Vancomycin, Linezolid, Tigecycline, Amikacin and Cotrimoxazole. Conclusion Risk factors of stroke-associated pneumonia in NICU of our hospital include advanced age, diabetes, dysphagia, hyperglycemia, hypoproteinemia, and high leukocyte count, etc. G- bacteria were the main pathogens. The main pathogens show severe multidrug resistance. Amikacin, Tigecycline can be used as the preferred antibacterial drugs, MRSA infection can also choose Vancomycin, Linezolid and other antibacterial drugs.
丑晓华1 高杏1 刘天雅1 王凤珍1 韩强1 张贤成2. 我院NICU卒中相关性肺炎的危险因素与抗感染治疗分析[J]. 中国医药导报, 2018, 15(15): 178-181.
CHOU Xiaohua1 GAO Xing1 LIU Tianya1 WANG Fengzhen1 HAN Qiang1 ZHANG Xiancheng2 . Analysis on the risk factors and anti-infective treatment of stroke-associated pneumonia in NICU in our hospital. 中国医药导报, 2018, 15(15): 178-181.